Sequential processing of amyloid precursor protein by β-and γ-secretases generates Alzheimer's disease (AD)-associated β-amyloid peptides. Recently it was reported that the transmembrane protein p23/TMP21 associates with γ-secretase, and negatively regulates β-amyloid production. Despite the link between p23 function and AD pathogenesis, the expression of p23 has not been examined in the brain. Here, we describe the detailed immunohistochemical characterization of p23 expression in rodent and human brain. We report that p23 is co-expressed with γ-secretase subunits in select neuronal cell populations in rodent brain. Interestingly, the steady-state level of p23 in the brain is high during embryonic development and then declines after birth. Furthermore, the steady-state p23 levels are reduced in the brains of individuals with AD. We conclude that p23 is expressed in neurons throughout the brain and the decline in p23 expression during postnatal development may significantly contribute to enhanced β-amyloid production in the adult brain.
Introduction
Alzheimer's disease (AD) is pathologically characterized by the cerebral deposition of 39-to 43-amino acid β-amyloid peptides (Aβ) in the brain of afflicted individuals. Sequential proteolysis of amyloid precursor protein (APP) by β-and γ-secretases generate Aβ (Iwatsubo, 2004; Vassar, 2004) . γ-secretase is a multimeric transmembrane protein complex containing presenilins (PS1 or PS2), nicastrin, APH-1 and PEN-2 as core subunits (Iwatsubo, 2004) . Recently, p23 (also called TMP21) was identified as regulatory components of γ-secretase complex (Chen et al., 2006) . p23 is a member of p24 family proteins, which are highly conserved type I transmembrane proteins involved in the coat protein (COP) I and II vesicle mediated cargo transport between ER and Golgi (Barlowe, 2000; Blum et al., 1999) . p24 family proteins have proposed to regulate COP vesicle budding, ER quality control, organization of the Golgi apparatus, and the formation of tubular transport intermediates (Bethune et al., 2006; Simpson et al., 2006) .
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In mammals, members of the p24 family proteins function as homo and heterodimers (Jenne et al., 2002) . A yeast Saccharomyces cerevisiae mutant strain with deletion of all members of the p24 family was viable, and showed delay in the secretory pathway trafficking of select proteins (Belden and Barlowe, 2001; Springer et al., 2000) . In the nematode Caenorhabditis elegans reducing the activity of the p24 family member SEL-9 increased the cell surface accumulation of transport-defective mutants of the Notch homologues, GLP-1 and LIN-12 (Wen and Greenwald, 1999) . In the fly Drosophila, loss of function mutations in p24 homologues reduced signaling associated with the TGF-β homologue, Dpp (Bartoszewski et al., 2004) . Mice with homozygous disruption of p23 alleles exhibited early embryonic lethality, underscoring the physiological significance of p24 family proteins (Denzel et al., 2000) .
An important link between p23 function and Aβ production was uncovered when it was found that p23 associates with γ-secretase complexes (Chen et al., 2006) . Interestingly, reducing p23 expression results in increased γ-secretase cleavage of APP in intact cells and cellfree Aβ assays (Vetrivel et al., 2007) . Moreover, knockdown of p23 expression conferred biosynthetic stability to nascent APP, allowing its efficient maturation, surface accumulation, and cleavage by α-and β-secretases (Vetrivel et al., 2007) . These studies clearly establish that p23 is a negative modulator of Aβ production.
At present, there is no published report on the distribution and relative abundance of p23 in the central nervous system. Here, we performed detailed characterization on the localization of p23 in the
